Podcasts about faron

Fun facts about music legends Bing Crosby and Faron Young. 

W tym odcinku podcastu „Historia w roli głównej” wracamy do niezwykłej postaci Jadwigi Kaliskiej – kobiety, która przez ponad czterdzieści lat stała u boku Władysława Łokietka i odegrała ogromną rolę w odbudowie Królestwa Polskiego. To opowieść o królowej, która nie była jedynie żoną monarchy, ale aktywną uczestniczką politycznych rozgrywek XIV wieku.Przyglądamy się momentom, w których Jadwiga musiała wykazać się nie tylko odwagą, ale również politycznym wyczuciem. Poznacie kulisy konfliktu z biskupem Janem Muskatą, jednego z najgroźniejszych przeciwników Łokietka, oraz historię walki o utrzymanie władzy w Krakowie. Opowiem także o buncie wójta Alberta i dramatycznej obronie Wawelu, podczas której Jadwiga została sama z dziećmi, podczas gdy całe państwo wisiało na włosku.Nie zabraknie również historii o kulisach koronacji Łokietka w 1320 roku, symbolice Szczerbca oraz trudnych relacjach z papiestwem. To właśnie wtedy Jadwiga udowodniła, że doskonale rozumie mechanizmy średniowiecznej polityki i potrafi poruszać się w świecie dyplomacji, wpływów oraz kościelnych układów.☕ Chcesz wesprzeć podcast? Link do ⁠⁠⁠⁠BuyCoffee ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Koronacja Władysława Łokietka w 1320 roku miała być symbolem odrodzenia Królestwa Polskiego. Ale za tym spektaklem polityki, ambicji i walki o władzę stała również ona — Jadwiga Kaliska. Kobieta, która przez lata żyła w ukryciu, chroniła dzieci, przetrwała wygnanie męża i obserwowała, jak Czesi przejmują polskie ziemie. A mimo to nie została złamana.W tym odcinku wracam do serii „Władczynie Polski” i zabieram Was w czasy rozbicia dzielnicowego, gdzie sojusze zmieniały się szybciej niż granice księstw, a walka o koronę przypominała scenariusz „Gry o tron”. Będą polityczne układy, zdrady, tajemnicze śmierci, ucieczki i szturm na Wawel.Poznamy młodą Jadwigę Kaliską — Piastównę wychowaną w cieniu świętych i ascetycznych tradycji — oraz człowieka, z którym związała swój los: ambitnego, sprytnego i bezwzględnie upartego Łokietka.To dopiero początek historii królowej, która przez dekady miała wpływać na losy Polski i Węgier.☕ Chcesz wesprzeć podcast? Link do ⁠⁠BuyCoffee ⁠⁠⁠⁠

The country fiddler, singer and songwriter is best known for writing "A Satisfied Mind", and spent much of his later career touring with Faron Young. 

Faron Pharmaceuticals Limited (AIM:FARN) CEO Dr Juho Jalkanen talked with Proactive's Stephen Gunnion about the company's planned €40 million rights offering and the next development stage for its lead immunotherapy candidate, bexmarilimab. Jalkanen explained that the planned capital raise comes at what he described as a pivotal stage for the company. The AIM and Nasdaq-listed Finnish biotech has completed an open-label phase I/II trial evaluating bexmarilimab in patients with higher-risk myelodysplastic syndromes (MDS), which produced encouraging results. The company is now preparing to advance the program into a blinded, randomised phase II trial, considered the gold standard in pharmaceutical development. Jalkanen highlighted that the main goal of the upcoming study is to measure complete remission rates among patients receiving the treatment. He explained that the key milestone will arrive relatively quickly once patients are enrolled. As he noted, “the absolute key and primary goal of the study is the complete remission rate readout… usually comes after three or so months after patients have gone on the drug.” The CEO also emphasised the broader potential of bexmarilimab beyond MDS. According to Jalkanen, strong data from the earlier trial has generated significant interest among physicians, who are now initiating investigator-led studies exploring the therapy across multiple cancer types and in combination treatments. Funding from the proposed raise is expected to extend Faron Pharmaceuticals' cash runway into late 2027, supporting the randomised phase II study while additional investigator-initiated trials generate data in the meantime. Jalkanen said this approach should create a steady flow of clinical updates for investors as the program progresses. For more interviews and market insights, visit the Proactive YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss future updates. #FaronPharmaceuticals #Bexmarilimab #BiotechInvesting #CancerResearch #Immunotherapy #MDS #ClinicalTrials #BiotechStocks #HealthcareInnovation #AIMStocks

In this episode, host David Abrams is in conversation with Faron Brazis, Tenant Engagement Manager at Hobbs Brook Real Estate. Faron shares her journey into tenant engagement and how the role continues to evolve as the workplace changes. She brings a unique background spanning politics, customer service, and event planning, which has shaped her people-first approach to creating meaningful workplace experiences. We discuss how suburban office environments are adapting to meet changing tenant expectations, the growing role of hospitality in commercial real estate, and why human connection remains essential even as technology becomes more embedded in buildings. Faron shares insights on data integration challenges, sustainability initiatives, and how offices are becoming destinations rather than just places to work. She also explains how suburban office spaces are adapting to provide city-like conveniences for today's tenants.Continue listening for a conversation about where tenant engagement is headed and how authenticity, hospitality, and creativity are shaping the future of the workplace.Subscribe to TEN so you never miss an episode of the Tenant Experience Network.

Dr. Petri Bono, Chief Medical Officer at Faron Pharmaceuticals, describes the development of bexmarilimad, a novel first-in-class immunotherapy that, unlike existing checkpoint inhibitors targeting T cells, targets the Clever 1 receptor on macrophages. This treatment is designed to reprogram the tumor microenvironment by switching marcophages from suppressive to active, enabling the patient's immune system to recognize and attack cancer cells. The primary disease target is higher-risk Myelodysplastic syndromes because the cancer cells in virtually all MDS patients express the Clever 1 target. Petri explains, "We are developing a completely new type of treatment. Currently, cancer patients are treated with immunotherapies called checkpoint inhibitors that target immune checkpoints. But our approach is targeting completely different cells, not T cells, but rather macrophages. And that's why we are first in class with a novel mode of action. And that's why it's important that these macrophages are shown to, for example, contribute to treatment resistance in many tumors." "Clever 1 actually is a receptor that was identified about 20 years ago. It found a certain macrophage as well as myeloid cells. And Clever 1 keeps the immune system in a tolerant and suppressive state. In cancer, for example, these Clever 1-positive macrophages essentially help the malignancy grow instead of helping to fight against it. And then our approach is that we want to block Clever 1 with our monoclonal antibody, bexmarilimab. So those macrophages switch the phenotype into an active antigen, preventing a pro-inflammatory state, and this reawakens immune surveillance. It allows T cells in the system to actually recognize the malignant cells themselves as dangerous and mount a proper antitumor response. So, a completely new mode of action by targeting Clever 1, we are not just adding another cytotoxic mechanism. We are removing the immune break and enabling the patient's own immune system to do the job that it was originally designed to do."  #FaronPharmaceuticals #BloodCancer #MDS #MyelodysplasticSyndrome #HR-MDS #CancerResearch #novelimmunotherapy #Bexmarilimab #Clever1 faron.com Download the transcript here

Dr. Petri Bono, Chief Medical Officer at Faron Pharmaceuticals, describes the development of bexmarilimad, a novel first-in-class immunotherapy that, unlike existing checkpoint inhibitors targeting T cells, targets the Clever 1 receptor on macrophages. This treatment is designed to reprogram the tumor microenvironment by switching marcophages from suppressive to active, enabling the patient's immune system to recognize and attack cancer cells. The primary disease target is higher-risk Myelodysplastic syndromes because the cancer cells in virtually all MDS patients express the Clever 1 target. Petri explains, "We are developing a completely new type of treatment. Currently, cancer patients are treated with immunotherapies called checkpoint inhibitors that target immune checkpoints. But our approach is targeting completely different cells, not T cells, but rather macrophages. And that's why we are first in class with a novel mode of action. And that's why it's important that these macrophages are shown to, for example, contribute to treatment resistance in many tumors." "Clever 1 actually is a receptor that was identified about 20 years ago. It found a certain macrophage as well as myeloid cells. And Clever 1 keeps the immune system in a tolerant and suppressive state. In cancer, for example, these Clever 1-positive macrophages essentially help the malignancy grow instead of helping to fight against it. And then our approach is that we want to block Clever 1 with our monoclonal antibody, bexmarilimab. So those macrophages switch the phenotype into an active antigen, preventing a pro-inflammatory state, and this reawakens immune surveillance. It allows T cells in the system to actually recognize the malignant cells themselves as dangerous and mount a proper antitumor response. So, a completely new mode of action by targeting Clever 1, we are not just adding another cytotoxic mechanism. We are removing the immune break and enabling the patient's own immune system to do the job that it was originally designed to do."  #FaronPharmaceuticals #BloodCancer #MDS #MyelodysplasticSyndrome #HR-MDS #CancerResearch #novelimmunotherapy #Bexmarilimab #Clever1 faron.com Listen to the podcast here

Niewiele o niej wiemy, jak z resztą o sporej ilości księżniczek, które wiązały się z Piastami okresu rozbicia dzielnicowego. Mówi się o niej, że dała początek dynastii linii mazowieckiej, która trwała aż do 1526 roku. Brak odpowiedniej ilości źródeł nie pozwala stwierdzić, skąd dokładnie się wywodziła ani kiedy i gdzie przyszła na świat. To, czym dysponujemy to szczątkowe informacje z różnych źródeł, które dają nam mgliste pojęcie o jej osobie. W tym odcinku spróbujemy połączyć je wszystkie w całość, a z pomocą przyjdą nam historycy oraz ich opracowania. Przedstawiam wam Perejasławę Halicką, żonę Siemowita I Mazowieckiego.Postaw mi wirtualną kawę: Buy coffeeInstagram: Historia w roli głównejŹródła:“Małżeństwa Królewskie - Piastowie”, J.Besala, wyd.Bellona “Święte i Tygrysice”, B.Faron, wyd. Astra“Ruskie żony polskich władców”, M.Samp, wyd.Lira“Drapieżny ród Piastów”, S.Leśniewski, wyd. Wydawnictwo Literackie

Możecie mnie wesprzeć: buycoffeKonto na IG: Historia w roli głównejCórka wygnanego księcia, która została cesarzową Hiszpanii.Ryksa Śląska przemierzyła średniowieczną Europę od Wrocławia po León i od Arles po Baden, stając się pionkiem w grze potężnych władców – ale też symbolem politycznej jedności kontynentu. Jej życie to opowieść o tym, jak kobiety bez własnego głosu potrafiły kształtować historię.Poznaj niezwykłą biografię jednej z najwyżej postawionych Piastówien w dziejach.Źródła:“Małżeństwa Królewskie - Piastowie”, J.Besala, wyd.Bellona “Święte i Tygrysice”, B.Faron, wyd. Astra“Drapieżny ród Piastów”, S.Leśniewski, wyd. Wydawnictwo Literackie

Ryksa Bolesławówna: królowa, która grała własną grę?Wyruszamy z Polski roku 1116 wprost na dwory Skandynawii, gdzie jedna córka Bolesława Krzywoustego musi w błyskawicznym tempie nauczyć się reguł wielkiej polityki albo utonąć. Między sojuszami pieczętowanymi ślubami, świętami przeradzającymi się w tragedię i nieustanną walką o korony, Ryksa staje się kluczem do układanki, w której cesarz, papież i północni królowie pociągają za sznurki, a jednak to ona potrafi zmienić przeszkodzić im w tej partii szachów.Kim była: zakładniczką epoki czy rozgrywającą? Co łączy ją z dwiema koronami i pewnym „świątecznym” morderstwem, które wstrząsnęło Europą? I jak z tej historii wyrasta nowa gałąź władców Północy?Posłuchaj, jeśli lubisz średniowiecze bez pudru: z intrygą, żelazem i czasem, sprytem silniejszym niż miecz.Prowdzący: Adrianna Adamska - OsosińskaMożesz mnie wesprzeć poprzez postawienie mi wirtualnej kawy: KawaŹródła:B.Faron "Piastówny na tronach Europy", wyd. Astra, Kraków 2019 r.Saxo Gramatyk, Kronika Danii, tłum. J.WoluckiP.Jasienica "Polska Piastów", Warszawa 1985 r.

Faron Pharmaceuticals Limited (AIM:FARN) CEO Dr Juho Jalkanen talked with Proactive's Stephen Gunnion about the latest clinical data presented at the European Society for Medical Oncology (ESMO) Congress in Barcelona on its lead asset, bexmarilimab, in high-risk myelodysplastic syndromes (MDS). Jalkanen described the data as “truly game changing,” highlighting that combining bexmarilimab with hypomethylating agents (HMAs) yielded an 85% response rate—compared to 40% with standard of care alone. Importantly, the complete remission rate reached 45%, which he described as “one of the highest ever seen in this field.” The company has secured orphan drug designation and received clear FDA guidance supporting the possibility of accelerated approval based on response rate, particularly complete remission. Jalkanen emphasised the importance of normalising blood counts in this patient population, many of whom are severely anaemic and neutropenic. He also discussed new biomarker data showing strong Clever-1 engagement, especially in bone marrow—where disease often hides from traditional chemotherapy. Jalkanen said this highlights bexmarilimab as a “truly disease-modifying agent.” On funding, Jalkanen confirmed Faron is well capitalised into next year, with further financing under exploration to support the upcoming registration trial, including partnering and fundraising initiatives. For more interviews and updates, head over to Proactive's YouTube channel. Don't forget to like this video, subscribe to our channel, and turn on notifications so you never miss future content. #FaronPharmaceuticals #Bexmarilimab #MDS #BiotechNews #ClinicalTrials #FDAApproval #OrphanDrug #Immunotherapy #CancerResearch #ProactiveInvestors

Today I'm joined by Brent Faron, manager at Bo Beuckman Ford. We cover Brent's journey from cleaning cars to leading one of the Midwest's largest single-point buy centers, the AI tools he's using to acquire 100 cars a month, how a St. Louis Blues game changed his career trajectory, and much more. This episode is brought to you by: 1. OPENLANE - The world's best online dealer marketplace for used cars, bringing you exclusive inventory, simple transactions, and better outcomes. Learn more @ https://www.openlane.com 2. Lotlinx - Get the best possible market advantage on every vehicle transaction. Optimize operations and boost profits using artificial intelligence (AI) and machine learning. Learn more @ https://lotlinx.com 3. CDG Recruiting – Hire top dealership talent, fast. From sales managers to GMs and C-suite execs, we've placed over 1,000 roles across auto retail. Ready to scale without the hassle? Visit http://www.cdgrecruiting.com to get started. Check out Car Dealership Guy's stuff: For dealers: Industry job board ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://jobs.dealershipguy.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dealership recruiting ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.cdgrecruiting.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ Fix your dealership's social media ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.trynomad.co⁠⁠⁠⁠⁠⁠⁠⁠⁠ Request to be a podcast guest ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.cdgguest.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ For industry vendors: Advertise with Car Dealership Guy ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.cdgpartner.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ Industry job board ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://jobs.dealershipguy.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ Request to be a podcast guest ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.cdgguest.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ Topics: 02:00 How did Brent's career begin? 07:48 Learning from early mistakes? 13:21 Managing employees and ethics 17:32 What is a Buy Center? 23:47 How does the Buy Center work? 25:23 Managing recon and acquisition costs? 28:57 Tracking Buy Center success how? 30:11 How does AI help appraisals? 42:01 The Future of AI in dealerships Car Dealership Guy Socials: X ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠x.com/GuyDealership⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/cardealershipguy/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠tiktok.com/@guydealership⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ LinkedIn ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linkedin.com/company/cardealershipguy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Threads ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠threads.net/@cardealershipguy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/profile.php?id=100077402857683⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Everything else ➤ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dealershipguy.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Send us a textDr. Juho Jalkanen, M.D., Ph.D. is CEO and Founder of Faron Pharmaceuticals ( https://faron.com/ ), is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient's own immune system. The Company's lead asset bexmarilimab is currently being investigated in clinical trials as a potential therapy for patients with hematological cancers, with an initial focus on higher-risk myelodysplastic syndrome (HR MDS), in combination with other standard treatments.Dr. Jalkanen an experienced biopharmaceutical industry executive with extensive leadership experience across key functional areas including operations, business development, clinical development, medical and regulatory affairs.   Dr. Jalkanen earned a Master´s degree in economics and business administration from the Turku School of Economics and both his M.D. and Ph.D. degrees from the University of Turku. He is a fully licensed general practitioner and specialist in vascular surgery.#JuhoJalkanen #FaronPharmaceuticals #Bexmarilimab #MyelodysplasticSyndrome #HematologicalCancers #HematologicalMalignancies #BloodCancer #AcuteMyeloidLeukemia #Clever1 #Macrophages #Oncology #Immunooncology #Cancer #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Rory McGowan is joined by Dr Juho Jalkanen from Faron Pharmaceuticals. In this episode they discuss a new blood cancer trial has shown highly promising results, particularly for patients who have relapsed or live with hard-to-treat forms of the disease. https://faron.com/ 

Faron Pharmaceuticals CEO Dr. Juho Jalkanen joined Steve Darling from Proactive to discuss the company's presentation of Phase II data from its BEXMAB study during a Rapid Oral Abstract Session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, which has recently concluded. The BEXMAB study is evaluating bexmarilimab, Faron's novel humanized anti-Clever-1 antibody, in combination with azacitidine, the current standard-of-care, in patients with high-risk myelodysplastic syndromes (MDS). The Phase II data presented focused on two patient populations: frontline treatment-naïve (n=21) and relapsed/refractory (r/r) MDS (n=32), with the majority (66% and 80% respectively) classified as very high/high risk at baseline. Jalkanen emphasized the unmet medical need in these populations, particularly for r/r MDS patients who have failed prior hypomethylating agent (HMA) therapies and have limited treatment options. In this context, the BEXMAB results are highly encouraging, showing an estimated median overall survival (mOS) of 13.4 months in r/r MDS patients — more than double the typical 5–6 months under current standard-of-care. These findings not only validate the therapeutic potential of bexmarilimab but also support progression to a confirmatory registrational Phase III trial, which would evaluate bexmarilimab + azacitidine versus placebo + azacitidine in frontline high-risk MDS patients. The company has received prior FDA guidance on trial design and is preparing for an end-of-Phase II meeting to discuss key parameters, including the proposed primary endpoint of composite complete response (cCR), a measure strongly correlated with overall survival. #proactiveinvestors #faronpharmaceuticalsltd #aim #farn #firstnorth #faron #MDS #Phase2Results #ASCO2025 #BiotechNews #CancerResearch #Immunotherapy #FDAUpdate #Hematology #ClinicalTrials (edited)

Faronilla on käynnissä historiansa tärkeimmät soidintanssit. Lääkekehitysyhtiö neuvottelee potentiaalisten yhteistyökumppaneiden kanssa bexmarilimabin seuraavista askeleista. Kyse on isoista rahoista, parhaassa tapauksessa miljardeista.Faronin lääkeaihio on käynyt läpi toisen vaiheen eli faasi II:n tutkimukset. Yhtiö on kertonut tuloksista makupaloja, mutta perinpohjaisesti ne esitellään touko-kesäkuun taitteessa Chicagossa järjestettävässä merkittävässä ASCO-toimialatapahtumassa. Päärivitulokset ovat lupaavia. Bexmarilimab edennee lääketutkimuksen kolmanteen vaiheeseen eli faasi III:een.Voiko pienellä turkulaisfirmalla olla käsissään blockbuster, yli miljardin dollarin vuosimyyntiä takova lääke?Entä miksi ihmeessä Faron keräsi rahaa juuri ennen toisen vaiheen tutkimustulosten julkistamista?Ja milloin Faron alkaa tehdä tulosta - tällä hetkellä kun tase osoittaa 200 miljoonan euron tappiokertymää?Grillattavana Faronin toimitusjohtaja Juho Jalkanen.Yhteistyössä: Faron#lääkekehitys #verisyöpä #blockbuster

Unseren Nachtwächtern schlägt das letzte Stündlein - es sei denn, sie überwinden heute Nacht die finsteren Mächte in Waldheim. Wir bestreiten das epochale Finale dieser Staffel und stellen uns tapfer dem Geheimbund der Karben, dem Brudermörder Faron und der unheimlichen Macht des Feuers des Mondes.Gürtet eure treuen Hähnchenspieße und steht an der Seite der Weißen Eule!00:00:00 Onkel Wilhelms Tagebuch00:00:28 Hail and well met00:02:25 Shopping in Waldheim00:03:52 Mansurs Glaskugeln00:05:25 Unterm Galgen00:12:12 Der Rat der Eule00:15:09 Der Initiationsritus00:27:00 Onkel Wilhelms Tagebuch00:27:29 Drei Wege00:29:13 Ein "Pst!" am Wegesrand00:35:48 Ein Freund alter Tage00:38:56 Heiler wider Willen00:44:14 Farons Anwesen00:45:21 Tyger, Tyger…00:47:53 Die Kellertür00:51:03 Der Zweck und die Mittel00:52:30 Onkel Wilhelms Tagebuch00:52:55 Steine und Statuen00:54:29 Dunkle Zaubermacht00:58:17 Entdeckt!00:59:38 Die Zeremonie der Karben01:04:58 Das Wasser der Quelle01:09:03 "Faron, Ihr seid verhaftet!"01:11:56 Verwirrspiel & Verführung01:16:51 Das letzte Gefecht01:21:13 Und wer räumt jetzt auf?01:28:54 Ruhe sanft, Wilhelm01:32:00 Epilog: Fackel von Sagiriton01:37:34 Epilog: Waldläufer des Königs01:39:41 Letzte Worte01:40:33 Onkel Wilhelms Tagebuch01:41:19 Abschlussbesprechung02:02:19 Teaser: Schiiiiii-foaaaan!►Über die Autoren: https://zweidrillinge.de/Musik-Credits:Michael Ghelfi ⁠⁠⁠⁠⁠www.michaelghelfi.com⁠⁠⁠⁠Hartwigmedia https://soundcloud.com/hartwigmediahttps://www.hartwigmedia.comMehr von uns:Linktree: ⁠https://linktr.ee/overthehillspodcast⁠Facebook: ⁠⁠⁠⁠⁠⁠https://www.facebook.com/oth.podcast⁠⁠⁠⁠⁠⁠Twitter: ⁠⁠⁠⁠⁠⁠https://twitter.com/OTHpodcastlords⁠⁠⁠⁠⁠⁠Spotify: https://open.spotify.com/show/6z1SWBMNmyR44qz9X95y9O?si=3851aa54d04f441cApple Podcasts: ⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/de/podcast/over-the-hills/id1560492808⁠⁠⁠⁠⁠⁠Website: ⁠⁠⁠⁠⁠⁠https://othpodcast.wordpress.com/

When Jean Harris met Herman Tarnower in the winter of 1966, she quickly fell in love the charming doctor. Having just come out of a disappointing twenty-year marriage, Harris was desperate to find the love and stimulating partnership she'd long dreamed of, and believed she'd finally found it in the intellectual Tarnower and the two would live happily ever after. But fourteen years later, Tarnower was dead and Harris was on trial for his murder, her fantasy of happily ever after having crumbled around her.Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesAlexander, Shana. 1983. Very Much a Lady: The Untold Story of Jean Harris and Dr. Herman Tarnower. New York, NY: Simon and Schuster.Clendinen, Dudley. 1981. "Jean Harrids as a witness: sad, humorous, cutting." New York Times, January 28: B2.Faron, James. 1980. "'Scarsdale Diet' doctor slain; headmistress charged." New York Times, March 12: A1.Feron, James. 1981. "Defiant Jean Harris sentenced to mandatory fifteen years." New York Times, March 21: 1.—. 1980. "Hard questioning is screening out Tarnower jurors." New York Times, November 13: B2.—. 1980. "Jean Harris jury told of clothing found 'slashed'." New York Times, December 3: B1.—. 1981. "Jurors in Harris trial re-enacted night of murder in deliberations." New York Times, February 26: A1.—. 1980. "Policeman tells how Mrs. Harris described fight." New York Times, December 12: B1.Haden-Guest, Anthony. 1980. "The headmistress and the diet doctor." New York Magazine, March 31.The People of the State of New York v. Jean S. Harris. 1981. 84 A.D.2d 63 (Appellate Division of the Supreme Court of New York, Second Department, December 30).United Press International. 1981. "Juror says Mrs. Harris's tesimony was the key to murder." New York Times, February 25: B2.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When Jean Harris met Herman Tarnower in the winter of 1966, she quickly fell in love the charming doctor. Having just come out of a disappointing twenty-year marriage, Harris was desperate to find the love and stimulating partnership she'd long dreamed of, and believed she'd finally found it in the intellectual Tarnower and the two would live happily ever after. But fourteen years later, Tarnower was dead and Harris was on trial for his murder, her fantasy of happily ever after having crumbled around her.Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesAlexander, Shana. 1983. Very Much a Lady: The Untold Story of Jean Harris and Dr. Herman Tarnower. New York, NY: Simon and Schuster.Clendinen, Dudley. 1981. "Jean Harrids as a witness: sad, humorous, cutting." New York Times, January 28: B2.Faron, James. 1980. "'Scarsdale Diet' doctor slain; headmistress charged." New York Times, March 12: A1.Feron, James. 1981. "Defiant Jean Harris sentenced to mandatory fifteen years." New York Times, March 21: 1.—. 1980. "Hard questioning is screening out Tarnower jurors." New York Times, November 13: B2.—. 1980. "Jean Harris jury told of clothing found 'slashed'." New York Times, December 3: B1.—. 1981. "Jurors in Harris trial re-enacted night of murder in deliberations." New York Times, February 26: A1.—. 1980. "Policeman tells how Mrs. Harris described fight." New York Times, December 12: B1.Haden-Guest, Anthony. 1980. "The headmistress and the diet doctor." New York Magazine, March 31.The People of the State of New York v. Jean S. Harris. 1981. 84 A.D.2d 63 (Appellate Division of the Supreme Court of New York, Second Department, December 30).United Press International. 1981. "Juror says Mrs. Harris's tesimony was the key to murder." New York Times, February 25: B2.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The country music singer gained popularity in the 1950s and '60s, charting several hit singles.

Q: How can you not fangirl over our latest guest? A. You can't. She's wise, she's funny, she's hot, of course she's none other than THE Kamilah Cole!!! @wordsiren 

Adam Cox is joined by Dr Juho Jalkanen, the CEO of Faron Pharmaceuticals. They discuss a groundbreaking development for cancer treatment, a promising new drug is set to enter late-stage clinical trials here in the UK. Bexmarilimab offers hope to the millions of people suffering from various deadly forms of blood cancer and leukaemia worldwide – where current treatment options are largely failing. https://www.faron.com/ 

Our Echoes of Wisdom journey is drawing to a close, as this week, we recount our experiences in three separate regions and learn what – and who! – is causing the rifts all over Hyrule! We're talking about Eldin Volcano, Faron Wetlands, and Holy Mount Lanayru, discussing all the wonderful new characters we met, the incredible dungeons, some of the best boss fights in 2D Zelda history, and the reveal of the source of the rifts! There's tons happening this week, strap in as we head towards the finish line! There will be spoilers for all three regions in this episode, so proceed with caution!     Download!   Support The Zelda Cast on Patreon! Subscribe to receive the monthly bonus show ‘The Zelda Cast Top Tens! Follow The Zelda Cast! The Zelda Cast (@TheZeldaCast) Andy Spiteri (@Spiteri316) Alasyn Eletha (@AlasynEletha) Twitch x Facebook x Discord x Tik-Tok x BlueSky Advertise on The Zelda Cast! See Options Here! Subscribe to The Zelda Cast! Apple Podcasts x Podbean x Spotify x iTunes x Google Podcasts x iHeart Radio x PlayerFM Grab The Zelda Cast Merch! Official Zelda Dungeon Merch store

Our Echoes of Wisdom journey is drawing to a close, as this week, we recount our experiences in three separate regions and learn what – and who! – is causing the rifts all over Hyrule! We're talking about Eldin Volcano, Faron Wetlands, and Holy Mount Lanayru, discussing all the wonderful new characters we met, the incredible dungeons, some of the best boss fights in 2D Zelda history, and the reveal of the source of the rifts! There's tons happening this week, strap in as we head towards the finish line! There will be spoilers for all three regions in this episode, so proceed with caution!     Download!   Support The Zelda Cast on Patreon! Subscribe to receive the monthly bonus show ‘The Zelda Cast Top Tens! Follow The Zelda Cast! The Zelda Cast (@TheZeldaCast) Andy Spiteri (@Spiteri316) Alasyn Eletha (@AlasynEletha) Twitch x Facebook x Discord x Tik-Tok x BlueSky Advertise on The Zelda Cast! See Options Here! Subscribe to The Zelda Cast! Apple Podcasts x Podbean x Spotify x iTunes x Google Podcasts x iHeart Radio x PlayerFM Grab The Zelda Cast Merch! Official Zelda Dungeon Merch store

Saints du jour 2024-04-09 Bienheureuse Célestine Faron by Radio Maria France

The world is coming to our doorstep. There are around 1 million international students in the US. The top sending countries are China and India, countries it is often difficult to send missionaries to. Do you have a college close to your church? In these 5 podcasts, learn actions you can take to minister to these students. Josh Chapman and Faron Thebeau serve as pastors at Mosaic Church Rolla, reaching students at Missouri S&T. #NAFWB #BetterTogether #College #CollegeMinistry #Outreach #InternationalStudents

Faron Dice, National Director of Partnerships for OneChild, joins Carmen again to share more stories of children living in poverty around the world whose lives were transformed by being sponsored by people like you through OneChild. Sponsor a child now!  

One Child's National Director of Radio and Artist Engagement, Faron Dice joins the program to share their mission. He talks about how sponsoring children changes their lives, the goal of opening up new Hope Centers around the world, and much more. Faith Radio's Amanda Nydam also joins to share her recent experience with One Child on a trip to Nicaragua. If you would like to sponsor a child, there is no better time than right now! To sponsor a child, click here.

Faron Dice, national director of partnerships for OneChild, talks about what he's seen of the kids who are sponsored and able to be in church-run Hope Centers in some of the poorest countries in the world. Sponsor a child now!

Exploring, according to Jay, the most beautiful area of Hyrule.Welcome to Hyrule Field Report, a Tears of the Kingdom audio playalong podcast! Join us next year to enter Lurelin.Sharing the podcast, rating and reviewing are all always appreciated!We're on twitter: https://twitter.com/HyruleFieldPodAnd facebook: https://www.facebook.com/profile.php?id=100091553694155We are an area-by-area audio playthrough pod about #TearsOfTheKingdom.Apple podcasts: https://podcasts.apple.com/us/podcast/hyrule-field-report/id1687039323…Spotify: https://open.spotify.com/show/7mDuNpbOQPl3SThTuWTuYF…Youtube: https://www.youtube.com/@HyruleFieldPodAnd the classic RSS: https://feeds.transistor.fm/hyrule-field-report…#Zelda #LegendofZelda #TheLegendofZelda #TLoZ #TotK #BreathoftheWild #BotW #ZeldaPodcastAnd please check out our other podcasts and consider giving your support!https://patreon.com/PodcastioPodcastius ★ Support this podcast on Patreon ★

Doug Faron is the Co-Founder and Managing Partner of Shoreham Capital, a privately-held real estate firm focused on the investment and development of residential and mixed-use projects in the Southeast, Sunbelt, and East Coast regions of the United States.Shoreham Capital focuses on value-add opportunities, ground-up rental developments, adaptive reuse, and residential alternatives, including single-family rentals and build-to-rent communities.With over 15 years of private equity and real estate experience, Doug has overseen $10+ billion of real estate investments and developments across multiple asset classes across the United States. Prior to founding Shoreham Capital, Doug spent time in corporate private equity and investment banking, and most recently spent the last 10 years at the CIM Group where he worked as Managing Director overseeing the firm's East Coast equity investment platform. Doug Faron is a real estate investor who has a great story to share and words of wisdom to impart for both beginning and veteran investors alike, so grab your pen and paper, buckle up and enjoy the ride. Want to get in contact with Doug Faron? Reach out at https://shorehamcapital.com/.Want to become financially free through commercial real estate? Check out our eBook to learn how to jump start a cash flowing real estate portfolio here https://www.therealestateinvestingclub.com/real-estate-wealth-book  Enjoy the show? Subscribe to the channel for all our upcoming real estate investor interviews and episodes.  ************************************************************************  GET INVOLVED, CONNECTED & GROW YOUR REAL ESTATE BUSINESS  LEARN -- Want to learn the ins and outs of real estate investing? Check out our book at https://www.therealestateinvestingclub.com/real-estate-wealth-book  PARTNER -- Want to partner on a deal or connect in person? Email the host Gabe Petersen at gabe@therealestateinvestingclub.com or reach out on LinkedIn at https://www.linkedin.com/in/gabe-petersen/  WATCH -- Want to watch our YouTube channel? Click here: https://bit.ly/theREIshow  ************************************************************************   ABOUT THE REAL ESTATE INVESTING CLUB SHOW   Hear from successful real estate investors across every asset class on how they got started investing in real estate and then grew from their first deal to a portfolio of cash-flowing properties. We interview real estate pros from every asset class and learn what strategies they used to create generational wealth for themselves and their families. The REI Club is an interview-based real estate show that will teach you the fastest ways to start and grow your real estate investing career in today's market - from multifamily, to self-storage, to mobile home parks, to mix-use industrial, you'll hear it all! Join us as we delve into our guests career peaks and valleys and the best advice, greatest stories, and favorite tips they learned along the way. Want to create wealth for yourself using the vehicle of real estate? Getting mentorship is the fastest way to success. Get an REI mentor and check out our REI course at https://www.therealestateinvestingclub.com.  #realestateInterested in becoming a passive investor in one of our projects? Kaizen Properties, is looking for passive investors for our upcoming deals. We invest in what are known as “recession resistant assets”: self storage, MH & RV parks, and industrial properties. If you are interested, go to the website and click on the “Invest with Us” button at the bottom of the page.Support the show

Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.

Doug is a seasoned real estate investor who KNOWS the State of Florida. Through his firm, Shoreham Capital, Doug engages in building residential properties to rent. He discusses how it is easier to reach critical mass with build to rent as opposed to sourcing one-off deals and spends a lot of time discussing the Florida market...where he likes and what he looks for.   Key Discussion Points [01:20] Introduction by Eric & Steven [10:20] About our guest: Doug Faron [11:32] How did you get into this side of the business? And what's your vision? [14:30] Which areas were you focusing on doing your "build to rent"? [15:31] What led you to focus on residential? [21:05] What are you seeing in the residential market with regard to rent / prices? And where do you see the future headed? [25:12] What market conditions are you seeing in south Florida? What about with office / commercial? [31:23] Re: the "build to rent", when you develop, how do you determine your holding period before you sell? [35:43] Which areas of Florida do you like? And what areas are you a little uncomfortable with right now? [37:19] Do you see any reprieve on constructions costs? [42:08] What is your capital stack looking like right now? [45:13] How can folks reach you? [47:30] What's the cost per "door" for single and multifamily home? [49:51] Closing comments by Eric & Steven     About Our Guest Doug Faron is a co-founder and managing partner at Shoreham Capital. He is a real estate leader and skilled dealmaker specializing sourcing, capitalizing, structuring, and executing debt and equity transactions throughout the United States. Doug oversees all aspects of his firm including the acquisition, capitalization, development, and management of their projects.   Doug graduated from Brown University with a dual concentration in international relations and economics and received his MBA from Northwestern University's Kellogg School of Management. He lives in Palm Beach, Florida with his wife and two children.   GUEST CONTACT INFO Email: doug@ShorehamCapital.com

Note: There is something big in this region that we are not covering in this episode and will come back later It's another detour through the tropical south region of Faron

The new director of the BAIA Foundation, Faron Manuel returns to the Noize! Faron and JBarber talk about his years of experience as a curator and writer that took him from Clark Atlanta Museum as a docent to the High Museum of Art and now his new role at Black Art In America. Faron talks about his plans for the foundation, new partnerships and programming on the horizon, and curating in the contemporary art market. We dive into the upcoming Fine Art Print Fair and his thoughts on the work of Richard Mayhew. More of that good art talk you love on the Noize! Listen, subscribe, and share!Episode 177 topics include:being an informed collector and artistworking on the Black Art in America Foundationworking at the High Museum of Artpartnerships with the Future Foundationreal-life experience in institutionscurating Better Days: Joy and Revolutionthesis about Richard MayhewFine Art Print Fair at BAIA GalleryFaron Manuel is the Director of the Black Art In America (BAIA) Foundation. A 501c3 organization that provides funding and professional development opportunities for Black artists and arts professionals in Atlanta and beyond. Before joining the BAIA Foundation, Manuel oversaw two Mellon Foundation-funded curatorial fellowship grants at the High Museum of Art in Atlanta from 2016-2023. Before joining the High Museum, he was the Special Projects Curatorial Assistant to the Clark Atlanta University Art Museum Director. He also served as the Assistant Editor at Black Art In America from 2015-2016, where he regularly interviewed collectors and reported widely on contemporary art.Manuel earned his B.A. in History from Clark Atlanta University in 2015, where he completed several museum fellowships. He has worked as an independent curator and art writer with notable collections and institutions over the years, doing much to expand the footprint of early-career artists. He was presented with the Hammonds House Honors Award for Curatorial Excellence in 2019 and recently served as a Resource Specialist for the Aspen Institute's 2022 Fall Workshop Series on grant program development.See more: BAIA Welcomes Faron Manuel As Director Of BAIA Foundation Presented by: Black Art In AmericaFollow us:StudioNoizePodcast.comIG: @studionoizepodcastJamaal Barber: @JBarberStudioSupport the podcast www.patreon.com/studionoizepodcast

Welcome to The Saint of the Day Podcast, a service of Good Catholic and The Catholic Company. Today's featured saint is Blessed Katarzyna Faron.  If you like what you heard, share this podcast with someone you know, and make sure to subscribe!

Saints du jour 2023-04-09 Bienheureuse Célestine Faron by Radio Maria France

Josh Chapman & Faron Thebeau of Mosaic Church Rolla presented this seminar at the 2022 Leadership Conference. Find more seminars from the conference here. 

WHAT'S AT STAKE IF YOU DO NOT PURSUE YOUR PASSIONS & DREAMS? AND … A BIG ANNOUNCEMENT! ONESHOT. ONELIFE. Is honored and excited to interview Faron Medhi, Natalie Pieper, and Jennifer Vannatta-Fisher live from Omaha, NE. Faron won Miss USA Teen, Natalie was 2nd Runner-Up Miss USA, and Jennifer is Co-Executive Director of Vanbros and Associates! Together we will dig deep into what it takes to pursue your passion and dreams, and, what's at stake you don't pursue them.

The recent Millard North grad who became the first Nebraskan to earn the national title joins us in the studio ahead of Nebraska's pageant weekend.

*This episode opens with a statement from Race Forward Executive Vice President Eric Ward on the killing of Tyre Nichols by Memphis police officers It's a new season for Momentum: A Race Forward Podcast and we're starting off in a big way with Race Forward President Glenn Harris, newly appointed Executive Vice President Eric Ward, and Senior Vice President of Strategic Partnerships Faron McLurkin. As three Black men, along with the other members of Race Forward's Executive Leadership Team, leading in the movement to advance racial equity, Glenn, Eric, and Faron speak to the fierce backlash to centering racial justice, the importance of instilling racially-equitable policies and practices across all levels of government,, and the importance of defending past gains while forging new, bold moves in the fight against white supremacy and institutional racism. Our panel also finds more lighthearted moments to kick back and discuss their favorite music artists, the metaphors music can have for the racial justice work we do, and exploring futurism to create bold moves. In the coming year, we have exciting things planned for the future of Momentum: A Race Forward Podcast as we bring you important conversations, in-depth racial justice analysis, and help build  the future of the movement with our listeners and supporters –– together.  Resources (by order of mention) Race Forward Urges Systemic Change In Light of Police Killing of Tyre Nichols; Continued Police Violence Against People of Color bit.ly/3jwghPV America has an antisemitism problem and victims cannot be left to fight it alone, rabbi says (via CNN)http://bit.ly/3j0g73j Executive Order On Advancing Racial Equity and Support for Underserved Communities Through the Federal Governmenthttp://bit.ly/3WFDjSa Government Alliance on Racial Equity (GARE)https://www.racialequityalliance.org/about/ Facing Race 2022: What's next for the movement for racial justice? What do we look forward to?https://bit.ly/3WZiDVe H.E.A.L. (Honest Education Action & Leadership) Together https://www.raceforward.org/heal-together How ‘Black Panther' Builds Complex Characters From the Politics of Colonization (via New York Times Critic's Notebook)http://bit.ly/3H7p8Q8 About Race Forward:  Race Forward catalyzes movement building for racial justice. In partnership with communities, organizations, and sectors, we build strategies to advance racial justice in our policies, institutions, and culture. Race Forward imagines a just, multiracial, democratic society, free from oppression and exploitation, in which people of color thrive with power and purpose. Follow Race Forward on social media Follow us on Facebook:www.facebook.com/raceforward Follow us on Twitter: www.twitter.com/raceforward Follow us on Instagram: www.instagram.com/raceforward Building Racial Equity (BRE) Trainings  www.raceforward.org/trainings Subscribe to our newsletter:www.raceforward.org/subscribe Executive Producers: Hendel Leiva, Cheryl Cato Blakemore

Dr. Eddie Moody interviews three pastors and ministry leaders who have taken advantage of the Know Your Community resource offered by the NAFWB in a partnership with Church Answers. Ben Crabtree is executive secretary for the Ohio State Association of Free Will Baptists; Ed Goode is pastor/church planter of Bridge Church in Champaign, Illinois; Faron Thebeau is pastor of The Mosaic Rolla. #NAFWB #BetterTogether

Joy's friend Faron joins the podcast to share his parents beautiful love story, as the family walks through dementia with his mom.Chicken of the Month Club! ➡️ fh.org/joy

It's a special episode for all of our local Nevada Wolf Pack fans. Faron Hand AKA “Meatball" is in the house! The former Big West player of the year shares his basketball story with us and some fun memories about his days playing in Reno.Faron Hand is from Philly and played in a special era of basketball where he played against familiar names like Rasheed Wallace, Aaron Mckee, Marc Jackson and many others. He went on to play for Nevada where he was the 1996-97 Big West Player of the year and helped put the Pack on the map. He shares great stories about growing up in Philly, The Sonny Hill League, his journey to Nevada and time with the Wolf Pack, his experience overseas, coaching, the story behind earning the nickname “Meatball” and MUCH more.This was an honor to learn from one of the Philly legends and Nevada greats. Plenty of laughs in this one with all of the Reno nostalgia and some great hoop stories. One thing is for damn sure… we need to get Faron Hand in the Reno Nevada Hall of Fame. Nevada was lucky to have him and we need to make this happen!Thank you Faron “Meatball” Hand!You can find this episode on Apple, Spotify or any source for podcasts.Follow us on social media for news, updates and highlight reels!Facebook - https://www.facebook.com/notin.myhouse.79Instagram- @Not_in_my_house_podcastTwitter - @NOTINMYHOUSEpc

One Child's National Director of Radio and Artist Engagement, Faron Dice, shares about the history and mission of One Child. | Paul Perrault talks about his time in Honduras with One Child and getting to see a first hand account of the work they're doing.